On January 30, 2025, Akero closed an underwritten public offering of 6.427 million common shares at $48.00 per share and ...

A new study finds that gut-specific TM6SF2 depletion exacerbates liver fat accumulation and dysbiosis in mice on high-fat ...

California biotech NGM Bio is slimming down as the company pivots focus, shedding around 75% of staff, pausing development of ...

What diseases are no longer an obstacle to military service Article 2-c. Clinically cured tuberculosis. This applies, in ...